These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37152294)

  • 1. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer.
    Metzler VM; de Brot S; Haigh DB; Woodcock CL; Lothion-Roy J; Harris AE; Nilsson EM; Ntekim A; Persson JL; Robinson BD; Khani F; Laursen KB; Gudas LJ; Toss MS; Madhusudan S; Rakha E; Heery DM; Rutland CS; Mongan NP; Jeyapalan JN
    Front Cell Dev Biol; 2023; 11():1116424. PubMed ID: 37152294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
    Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
    Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.
    Harris AE; Metzler VM; Lothion-Roy J; Varun D; Woodcock CL; Haigh DB; Endeley C; Haque M; Toss MS; Alsaleem M; Persson JL; Gudas LJ; Rakha E; Robinson BD; Khani F; Martin LM; Moyer JE; Brownlie J; Madhusudan S; Allegrucci C; James VH; Rutland CS; Fray RG; Ntekim A; de Brot S; Mongan NP; Jeyapalan JN
    Front Endocrinol (Lausanne); 2022; 13():1006101. PubMed ID: 36263323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics.
    Chianese U; Papulino C; Passaro E; Evers TM; Babaei M; Toraldo A; De Marchi T; Niméus E; Carafa V; Nicoletti MM; Del Gaudio N; Iaccarino N; Randazzo A; Rotili D; Mai A; Cappabianca S; Mashaghi A; Ciardiello F; Altucci L; Benedetti R
    Mol Metab; 2022 Oct; 64():101561. PubMed ID: 35944897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
    Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
    Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers.
    Teramoto Y; Yang Z; Matsukawa T; Najafi MAE; Goto T; Miyamoto H
    Am J Cancer Res; 2024; 14(9):4367-4377. PubMed ID: 39417173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.
    Haigh DB; Woodcock CL; Lothion-Roy J; Harris AE; Metzler VM; Persson JL; Robinson BD; Khani F; Alsaleem M; Ntekim A; Madhusudan S; Davis MB; Laursen KB; Gudas LJ; Rutland CS; Toss MS; Archer N; Bodi Z; Rakha EA; Fray RG; Jeyapalan JN; Mongan NP
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells.
    Wang Z; Gao S; Han D; Han W; Li M; Cai C
    Front Oncol; 2019; 9():721. PubMed ID: 31428587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer.
    Liu B; Kumar R; Chao HP; Mehmood R; Ji Y; Tracz A; Tang DG
    Oncotarget; 2020 Nov; 11(46):4243-4252. PubMed ID: 33245716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of histone lysine demethylases in prostate cancer.
    Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
    Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.
    Karantanos T; Evans CP; Tombal B; Thompson TC; Montironi R; Isaacs WB
    Eur Urol; 2015 Mar; 67(3):470-9. PubMed ID: 25306226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
    O'Sullivan AG; Mulvaney EP; Kinsella BT
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
    Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing.
    Shah K; Gagliano T; Garland L; O'Hanlon T; Bortolotti D; Gentili V; Rizzo R; Giamas G; Dean M
    Oncogene; 2020 Sep; 39(39):6172-6189. PubMed ID: 32820253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion.
    Wang J; Yu Q; Qiu Z; Dai T; Wang S; Yang X; Evers BM; Wu Y
    Aging (Albany NY); 2020 Jan; 12(1):397-415. PubMed ID: 31901895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer.
    Chen Y; Lan T
    Urol Int; 2021; 105(5-6):337-353. PubMed ID: 32957106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Effects on Alcohol-induced Liver Fibrosis Are Controlled by a Notch-dependent Epigenetic Switch.
    Nataraj K; Schonfeld M; Rodriguez A; Sharma M; Weinman S; Tikhanovich I
    Cell Mol Gastroenterol Hepatol; 2024 Sep; ():101414. PubMed ID: 39349250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.